NYSE: MTXMinerals Technologies Inc Stock
$56.75+1.51 (+2.73%)
Updated Oct 31, 2025
MTX Price
$56.75
Fair Value Price
N/A
Market Cap
$1.77B
52 Week Low
$49.54
52 Week High
$86.49
P/E
N/A
P/B
1.05x
P/S
0.94x
PEG
N/A
Dividend Yield
0.58%
Revenue
$2.07B
Earnings
-$1.60M
Gross Margin
25.4%
Operating Margin
3.09%
Profit Margin
-0.1%
Debt to Equity
1.04
Operating Cash Flow
$200M
Beta
1.04
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
Dec 4, 2025
MTX Overview
Minerals Technologies Incorporated produces various specialty mineral, mineral-based, and synthetic mineral products, and supporting systems and services. Its Specialty Minerals segment sells calcium carbonate, limestone, and talc used in the paper, building materials, paint, automotive, and pharmaceutical industries. Its Refractories segment sells products for steel furnaces. The Performance Materials segment sells bentonite used in steel alloy casting and household products including cat litter. It sells its products in the U.S. and internationally. Minerals Technologies was incorporated in 1968 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MTX's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important MTX news, forecast changes, insider trades & much more!
MTX News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MTX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MTX was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MTX is good value based on its book value relative to its share price (1.05x), compared to the US Specialty Chemicals industry average (3.09x)
P/B vs Industry Valuation
MTX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more MTX due diligence checks available for Premium users.
Valuation
MTX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
12.51x
Market
41.65x
MTX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.05x
Industry
3.09x
MTX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MTX's financial health
Profit margin
Revenue
$532.4M
Net Income
$43.0M
Profit Margin
8.1%
MTX's Earnings (EBIT) of $64.10M... subscribe to Premium to read more.
Interest Coverage Financials
MTX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.5B
Liabilities
$1.7B
Debt to equity
1.04
MTX's short-term assets ($1.17B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MTX's short-term assets ($1.17B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MTX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$70.9M
Investing
-$37.6M
Financing
-$26.2M
MTX's operating cash flow ($199.80M)... subscribe to Premium to read more.
Debt Coverage Financials
MTX vs Specialty Chemical Stocks
Minerals Technologies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.